Sign up to save your podcasts
Or
Share Icahn v. Ackman
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Icahn v. Ackman
Rangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss the ongoing Bill Ackman / Carl Icahn feud over Herbalife (HLF). Then, they discuss the rational behind the massive premiums Allergan (AGN) paid for Tobira (TBRA) and Vitae (VTAE).
View all episodes
By Rangeley Capital PodcastRangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss the ongoing Bill Ackman / Carl Icahn feud over Herbalife (HLF). Then, they discuss the rational behind the massive premiums Allergan (AGN) paid for Tobira (TBRA) and Vitae (VTAE).